A case study of ex ante, value-based price and reimbursement decision-making: TLV and rimonabant in Sweden.
about
The Value of Medicines: A Crucial but Vague Concept.Market Access Agreements for pharmaceuticals in Europe: diversity of approaches and underlying conceptsRole of centralized review processes for making reimbursement decisions on new health technologies in Europe.Health technology funding decision-making processes around the world: the same, yet different.Societal values in the allocation of healthcare resources: is it all about the health gain?A new reimbursement system for innovative pharmaceuticals combining value-based and free market pricing.Pricing and reimbursement frameworks in Central Eastern Europe: a decision tool to support choices.Opening the gateways to market and adoption of regenerative medicine? The UK case in context.Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European countries.Achieving Good Glycemic Control Early After Onset of Diabetes: A Cost-Effectiveness Analysis in Patients with Type 1 Diabetes in Sweden.The Use of Surrogate and Patient-Relevant Endpoints in Outcomes-Based Market Access Agreements : Current Debate.Early evaluation and value-based pricing of regenerative medicine technologies.
P2860
Q30248857-4E63C693-1795-4613-8356-214EF6891084Q34044177-31DF9863-FBFF-4C3A-91CF-906B9AAAFE4FQ35454428-113D2A9F-A4B1-4DF9-9C2D-31C6B3DD6EF7Q37875051-D689566B-E89E-4F87-ADE4-062118797279Q37911500-81E9E5DF-CEE4-4492-86B9-B8ABE1E21117Q38016948-A7D7289C-BFF7-4FCF-A3B8-B083977FB8C3Q38223213-390B033D-B29C-4944-B817-C04DF7D6A9F8Q38795498-3AABE5AF-ABB9-4DCC-8BBB-C898120AF41AQ38902166-DA843FBB-6A2D-411F-864B-424C87EA1310Q47369149-76D62A8D-E050-4467-946D-4139B7794DD2Q48375673-18CA4F5A-115F-4FA1-8AAA-7139C6F94FADQ54714604-4CF09EDF-5EF4-44EB-9DAF-93C8F050D8B4
P2860
A case study of ex ante, value-based price and reimbursement decision-making: TLV and rimonabant in Sweden.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A case study of ex ante, value ...... TLV and rimonabant in Sweden.
@en
A case study of ex ante, value ...... TLV and rimonabant in Sweden.
@nl
type
label
A case study of ex ante, value ...... TLV and rimonabant in Sweden.
@en
A case study of ex ante, value ...... TLV and rimonabant in Sweden.
@nl
prefLabel
A case study of ex ante, value ...... TLV and rimonabant in Sweden.
@en
A case study of ex ante, value ...... TLV and rimonabant in Sweden.
@nl
P1476
A case study of ex ante, value ...... TLV and rimonabant in Sweden.
@en
P2093
Knut Odegaard
Ulf Persson
P2888
P304
P356
10.1007/S10198-009-0166-1
P577
2009-07-29T00:00:00Z